ストックスクリーナーアプリを入手
9.24
12.00%
0.99
アフターアワーズ：
9.24
前日終値:
$8.25
開ける：
$8.33
24時間の取引高:
68,174
Relative Volume:
0.85
時価総額：
$257.00M
収益：
$21.25M
当期純損益:
$-16.05M
株価収益率:
-15.15
EPS:
-0.61
ネットキャッシュフロー:
$-17.14M
1週間 パフォーマンス:
+13.10%
1か月 パフォーマンス:
+5.24%
6か月 パフォーマンス:
+41.72%
1年 パフォーマンス:
+47.84%
1日の値動き範囲:
$8.25
$9.29
1週間の範囲:
$7.93
$9.29
52週間の値動き範囲:
$3.96
$9.30
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
名前
Fennec Pharmaceuticals Inc
セクター
電話
(919) 636-4530
住所
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
9.24 | 227.85M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-22 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 開始されました | CapitalOne | Overweight |
| 2022-08-08 | 再開されました | Craig Hallum | Buy |
| 2020-06-05 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 開始されました | Goldman | Buy |
Fennec Pharmaceuticals Inc (FENC) 最新ニュース
Can trapped investors hope for a rebound in Fennec Pharmaceuticals Inc.Free Smart Allocation Stock Pick Insights - Newser
Measuring Fennec Pharmaceuticals Inc.’s beta against major indicesCapital Secure Pattern Signal Analysis Sheet - Newser
How to manage a losing position in Fennec Pharmaceuticals Inc.Free Daily Top Performing Stock Insights - Newser
Stocks In Play: Fennec Pharmaceuticals Inc. - Barchart.com
Fennec Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks
Why Fennec Pharmaceuticals Inc. is moving todayShort-Term Bounce Forecast for Oversold Stocks - Newser
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025 - The Manila Times
Fennec Pharmaceuticals to announce Q2 2025 financial results on Aug. 14. - AInvest
Fennec Pharmaceuticals Sets Q2 Earnings Date: Specialty Pharma Company to Update Investors August 14 - Stock Titan
Fennec Pharmaceuticals Inc. stock outlook for YEAREarly Entry Ideas with Momentum Potential - Newser
Real time pattern detection on Fennec Pharmaceuticals Inc. stockDividend Strategy Summary With 10-Year Outlook - Newser
Will Fennec Pharmaceuticals Inc. stock go up soonFree Opportunity Map for Daily Stock Trading - Newser
Adherex Technologies (FENC) to Release Earnings on Tuesday - Defense World
What makes Fennec Pharmaceuticals Inc. stock price move sharplyShort-Term Swing Opportunity Summary Sheet - Newser
How to interpret RSI for Fennec Pharmaceuticals Inc. stockPredictive System for Long-Term Stock Forecast - Newser
Fennec Pharmaceuticals FENC Q2 2025 Earnings Preview Downside Concerns Amid Product Vulnerability Issues - AInvest
How Fennec Pharmaceuticals Inc. stock performs during market volatilityLong-Term Signal Tracking and Profit Summary - Newser
Full technical analysis of Fennec Pharmaceuticals Inc. stockPredictive Model for Intraday Swing Forecast - Newser
Anterix Holds Virtual Annual Stockholders Meeting - The Globe and Mail
Paymentus Holdings: Strong Growth and Raised Guidance - The Globe and Mail
Using data filters to optimize entry into Fennec Pharmaceuticals Inc.Rapid Trade Forecast Based on Indicators - Newser
Evaluating Fennec Pharmaceuticals Inc. with trendline analysisCapital Protection Strategy With Risk Analysis - Newser
Adherex Technologies (NASDAQ:FENC) Trading Up 6.1% – Still a Buy? - Defense World
Is it too late to sell Fennec Pharmaceuticals Inc.Summary of Long-Term Buy Zone Stocks - Newser
Why Fennec Pharmaceuticals Inc. stock attracts strong analyst attentionEntry Signal Generator with Risk Metrics - Newser
Using economic indicators to assess Fennec Pharmaceuticals Inc. potentialFree Early Entry Tips With Low Risk Zone - Newser
What is the dividend policy of Fennec Pharmaceuticals Inc. stockCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Fennec Pharmaceuticals Inc. stockSuperior portfolio returns - Jammu Links News
How does Fennec Pharmaceuticals Inc. compare to its industry peersExceptional profit potential - Jammu Links News
Is Fennec Pharmaceuticals Inc. a good long term investmentDiscover undervalued opportunities early - Jammu Links News
Is it the right time to buy Fennec Pharmaceuticals Inc. stockDiscover undervalued stocks ready to soar - Jammu Links News
What are the technical indicators suggesting about Fennec Pharmaceuticals Inc.Tremendous growth opportunities - Jammu Links News
Does Fennec Pharmaceuticals Inc. stock perform well during market downturnsTrack top-performing stocks effortlessly - Jammu Links News
Should I hold or sell Fennec Pharmaceuticals Inc. stock in 2025Get ahead with breakthrough trading ideas - Jammu Links News
What data driven models say about Fennec Pharmaceuticals Inc.’s futureTrend Confirmation Scanner with Entry Focus - Newser
Fennec Pharmaceuticals Inc (FENC) 財務データ
収益
当期純利益
現金流量
EPS
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):